Concepedia

Annie Apffel

AA

Statistics

Publications

6

Citations

916

H-Index

6

Active since

2019

Affiliations

Harvard University(Current)

Broad Institute

Massachusetts General Hospital

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Annie Apffel is an author at Harvard University specializing in life sciences, immunology, and molecular oncology.

ORCID

Publications per year

2019–2023

6

Publications

6

WRN helicase is a synthetic lethal target in microsatellite unstable cancers

Edmond M. Chan, Tsukasa Shibue, James M. McFarland et al. · Nature · 2019 · 472 citations · Full text

, , +11

Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer

Tamara Ouspenskaia, Travis Law, Karl R. Clauser et al. · Nature Biotechnology · 2021 · 302 citations · Full text

, , +14

Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples

Susan Klaeger, Annie Apffel, Karl R. Clauser et al. · Molecular & Cellular Proteomics · 2021 · 57 citations · Full text

, , +16

Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer

Tamara Ouspenskaia, Travis Law, Karl R. Clauser et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 45 citations · Full text

, , +17

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma

Patrick C. Lee, Susan Klaeger, Phuong M. Le et al. · Journal of Clinical Investigation · 2022 · 29 citations · Full text

, , +17

1–5 of 6